Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 31:2022:7934868.
doi: 10.1155/2022/7934868. eCollection 2022.

Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium

Andrejs Erglis  1   2 , Inga Narbute  1   2 , Dace Sondore  2 , Sanda Jegere  1   2 , Indulis Kumsars  1   2 , Andis Dombrovskis  2 , Karlis Grikis  1   2 , Ieva Briede  1   2 , Kristine Dombrovska  2 , Karlis Trusinskis  2   3 , Alona Grave  2 , Martins Erglis  1   2 , Martins Kalejs  2   3 , Peteris Stradins  2   3 , Uldis Strazdins  1   2
Affiliations

Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium

Andrejs Erglis et al. J Interv Cardiol. .

Abstract

Objectives: The study aimed to investigate the long-term outcomes of a double stent scaffold strategy in patients with left main (LM) bifurcation lesions involving the ostium of the left circumflex artery (LCX), utilizing a drug-eluting stent (DES) in the LM extending into the left anterior descending artery (LAD) and a bioresorbable vascular scaffold (BVS) in the LCX ostium.

Background: The high occurrence of in-stent restenosis of the LCX ostium is the major limitation of percutaneous coronary intervention (PCI) for LM lesions with a two-stent strategy.

Methods: This was a single-center, prospective, single-arm study of 46 consecutively enrolled patients with a stable coronary artery disease and significant unprotected LM distal bifurcation disease. Patients underwent imaging-guided PCI using DES in the LM-LAD and BVS in the LCX using a T-stent or mini-crush technique. The primary outcome at four years was the composite of death, myocardial infarction, stroke, and target lesion revascularization (TLR).

Results: At four years, the primary outcome was identified in 9 patients (19.6%). All events were TLRs except one myocardial infarction due to BVS thrombosis. Seven of the eight TLRs were a result of side branch BVS restenosis. Univariate predictors of the 4-year outcome were higher LDL cholesterol and BVS size ≤2.5 mm. On multivariate analysis, LCX lesion preparation with a cutting balloon and post-procedure use of intravascular ultrasound for optimization were found to be independent protective factors of MACE.

Conclusions: In selected patients with LM distal bifurcation disease, an imaging-guided double stent scaffold strategy with DES in the LM and BVS in the LCX ostium was technically successful in all patients and was reasonably safe and effective for four years.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Study flowchart.
See this image and copyright information in PMC

References

    1. Takagi K., Naganuma T., Chieffo A., et al. Comparison between 1-and 2-stent strategies in unprotected distal left main disease: the milan and new-Tokyo registry. Circulation: Cardiovascular Interventions . 2016;9(11) doi: 10.1161/circinterventions.116.003359.e003359 - DOI - PubMed
    1. Kang S. J., Ahn J. M., Song H., et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circulation: Cardiovascular Interventions . 2011;4(6):562–569. doi: 10.1161/circinterventions.111.964643. - DOI - PubMed
    1. Chen X., Li X., Zhang J. J., et al. 3-Year outcomes of the DKCRUSH-V trial comparing DK crush with provisional stenting for left main bifurcation lesions. JACC: Cardiovascular Interventions . 2019;12(19):1927–1937. doi: 10.1016/j.jcin.2019.04.056. - DOI - PubMed
    1. Capodanno D. Bioresorbable scaffolds in coronary intervention: unmet needs and evolution. Korean Circulation Journal . 2018;48(1):24–35. doi: 10.4070/kcj.2017.0194. - DOI - PMC - PubMed
    1. Waksman R. Biodegradable stents: they do their job and disappear. Journal of Invasive Cardiology . 2006;18(2):70–74. - PubMed

MeSH terms

LinkOut - more resources